Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,994 | -22,799 | -16,241 | -10,044 | -4,161 |
| Depreciation Amortization | 100 | 361 | 175 | 83 | 95 |
| Accounts receivable | N/A | -59 | N/A | N/A | -69 |
| Accounts payable and accrued liabilities | N/A | 1,360 | 3,304 | 351 | 597 |
| Other Working Capital | 32,912 | 6,096 | 6,980 | 4,898 | 5,725 |
| Other Operating Activity | 753 | 653 | -1,878 | 630 | -160 |
| Operating Cash Flow | $25,771 | $-14,388 | $-7,659 | $-4,083 | $2,027 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179 | -560 | -323 | -125 | -68 |
| Investing Cash Flow | $-179 | $-560 | $-323 | $-125 | $-68 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 15,221 | N/A | 15,281 | N/A |
| Other Financing Activity | 0 | 0 | 15,221 | 0 | 0 |
| Financing Cash Flow | $N/A | $15,221 | $15,221 | $15,281 | $N/A |
| Exchange Rate Effect | 295 | -267 | -31 | -47 | -119 |
| Beginning Cash Position | 29,356 | 29,350 | 29,349 | 29,349 | 29,349 |
| End Cash Position | 55,242 | 29,356 | 36,558 | 40,374 | 31,189 |
| Net Cash Flow | $25,886 | $6 | $7,209 | $11,025 | $1,839 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,771 | -14,388 | -7,659 | -4,083 | 2,027 |
| Capital Expenditure | -179 | -560 | -323 | -125 | -68 |
| Free Cash Flow | 25,592 | -14,948 | -7,981 | -4,208 | 1,959 |